Fig. 3. LGG treatment decreases inflammation and increases gut barrier function and gene expression. A: Cytokine level for TNF in gut tissue (P value <0.001). B: Myeloperoxidase activity in day 8 pi gut tissue (P value <0.001). C: Cytokine level for IL4 in day 8 pi gut tissue (P value <0.001). D: Cytokine level for IL10 in day 8 pi gut tissue (P value <0.001). E: Occludin gene expression level with respect to NT (P value <0.05). F: Claudin1 gene expression level with respect to NT in day 8 pi gut tissue (P value <0.001). G: Claudin3 gene expression level with respect to NT in day 8 pi gut tissue (P value <0.001). H: Mucin2 gene expression level with respect to NT in day 8 pi gut tissue (P value <0.05). Data presented are the average of n = 3 mice per condition.